AngioDynamics to Participate in the Bank of America and Merrill Lynch 2009 Health Care Conference | AngioDynamics, Inc.
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News AngioDynamics, Inc. AngioDynamics to Participate in the Bank of America and Merrill Lynch 2009 Health Care Conference

AngioDynamics to Participate in the Bank of America and Merrill Lynch 2009 Health Care Conference

Company News - AngioDynamics, Inc.
AngioDynamics announced that it will present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009. AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, announced that it will present at the Bank of America and Merrill Lynch 2009 Health Care Conference in New York on May 13, 2009, at 3:20 p.m. Eastern Time. Jan Keltjens, president and CEO, and Joseph Gersuk, executive vice president and CFO of AngioDynamics, will review the Company's business strategy and historical financial results.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's website at: www.angiodynamics.com. The archived presentation will be available through May 29, 2009.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Source: AngioDynamics